Guangxi Ruikang Hospital
12
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
Role: collaborator
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
Role: collaborator
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Role: collaborator
A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema
Role: collaborator
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Role: collaborator
SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer
Role: collaborator
I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer
Role: collaborator
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.
Role: collaborator
Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors
Role: collaborator
Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
Role: collaborator
Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV
Role: collaborator
The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule
Role: collaborator
All 12 trials loaded